The difficulty of studying the association between pathway delays and survival in cancer - an example from bladder cancer

Scand J Urol. 2024 Oct 30:59:181-184. doi: 10.2340/sju.v59.42176.

¹ Transforming cancer OUtcomes through Research (TOUR), School of Cancer and Pharmaceutical Science, King's College London, UK. beth.russell@kcl.ac.uk.
² Institution of Translational Medicine, Lund University, Malmö, Sweden.
³ Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Northern Registry Centre, Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.
⁴ Transforming cancer OUtcomes through Research (TOUR), School of Cancer and Pharmaceutical Science, King's College London, UK; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
⁵ Transforming cancer OUtcomes through Research (TOUR), School of Cancer and Pharmaceutical Science, King's College London, UK.
⁶ Institution of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology Skåne University Hospital, Malmö, Sweden.

Abstract

N/A.